menu
    • menu

    Company profile for HAYA Therapeutics

    NEW Drugs in Dev: 1
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    HAYA Therapeutics is a precision therapeutics company that discovers and develops innovative tissue- and cell-selective genomic medicines for fibrotic diseases and other serious health conditions associated with aging, including cancer. The company’s discovery engine focuses on long non-coding RNAs (lncRNAs) within the “dark matter” of the human genome -- key tissue and cell-specific drivers of fibrosis and other disease...
    HAYA Therapeutics is a precision therapeutics company that discovers and develops innovative tissue- and cell-selective genomic medicines for fibrotic diseases and other serious health conditions associated with aging, including cancer. The company’s discovery engine focuses on long non-coding RNAs (lncRNAs) within the “dark matter” of the human genome -- key tissue and cell-specific drivers of fibrosis and other disease processes -- to identify novel targets and drug candidates with the potential for greater efficacy and safety than existing treatments.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HAYA TherapeuticsSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    SuperLab Suisse - Bâtiment Serine Route de la Corniche 6 1066 Epalinges, Laus...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.hayatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/haya-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    HAYA Therapeutics Doses First Cohort in Phase 1 HTX-001 Trial
    HAYA Therapeutics Doses First Cohort in Phase 1 HTX-001 Trial

    20 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-20/haya-therapeutics-announces-first-cohort-dosed-in-phase-1-clinical-trial-of-htx-001-an-investigatio

    PHARMIWEB
    20 May 2026
    Share Share
    Haya Therapeutics Moves San Diego Operations to Lilly Gateway Lab
    Haya Therapeutics Moves San Diego Operations to Lilly Gateway Lab

    03 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250603780426/en/HAYA-Therapeutics-Moves-San-Diego-Operations-to-Lilly-Gateway-Labs-to-Accelerate-Development-of-RNA-Guided-Therapeutics-Platform

    BUSINESSWIRE
    03 Jun 2025
    Share Share
    HAYA Therapeutics Raises $65M for Precision RNA-Guided Medicines
    HAYA Therapeutics Raises $65M for Precision RNA-Guided Medicines

    08 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250508776403/en/HAYA-Therapeutics-Raises-%2465-Million-in-Series-A-Funding-to-Deliver-Precision-RNA-Guided-Medicines-for-Chronic-and-Age-Related-Diseases

    BUSINESSWIRE
    08 May 2025
    Share Share
    HAYA Therapeutics to Present RNA-Guided Platform at ASGCT
    HAYA Therapeutics to Present RNA-Guided Platform at ASGCT

    02 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250502322005/en/HAYA-Therapeutics-to-Present-on-RNA-Guided-Regulatory-Genome-Platform-at-the-Annual-Meeting-of-the-American-Society-of-Gene-Cell-Therapy-ASGCT

    BUSINESSWIRE
    02 May 2025
    Share Share
    HAYA Therapeutics Appoints Dr. Richard as Chief Business Officer
    HAYA Therapeutics Appoints Dr. Richard as Chief Business Officer

    13 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250313318056/en/HAYA-Therapeutics-Appoints-Former-Exscientia-Executive-Dr.-Richard-Law-as-Chief-Business-Officer

    BUSINESSWIRE
    13 Mar 2025
    Share Share
    HAYA Therapeutics Names Jordan Shin As Chief Medical Officer
    HAYA Therapeutics Names Jordan Shin As Chief Medical Officer

    11 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240911282552/en

    BUSINESSWIRE
    11 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search